|
gptkbp:instanceOf
|
gptkb:drug
peptide
|
|
gptkbp:approvedBy
|
gptkb:FDA
2012
|
|
gptkbp:ATCCode
|
gptkb:A06AX04
|
|
gptkbp:brand
|
gptkb:Constella
gptkb:Linzess
|
|
gptkbp:CASNumber
|
gptkb:851199-59-2
|
|
gptkbp:contraindication
|
pediatric patients under 6 years
|
|
gptkbp:developer
|
gptkb:Allergan
gptkb:Astellas_Pharma
gptkb:Ironwood_Pharmaceuticals
gptkb:Forest_Laboratories
|
|
gptkbp:eliminationHalfLife
|
3 minutes (in plasma)
|
|
gptkbp:excretion
|
feces
|
|
gptkbp:hasMolecularFormula
|
C59H79N15O21S6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
linaclotide
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
guanylate cyclase-C agonist
|
|
gptkbp:metabolism
|
intestinal
|
|
gptkbp:origin
|
synthetic
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:proteinBinding
|
none
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL2105727
gptkb:DB08890
24873427
28536936
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
diarrhea
abdominal pain
flatulence
|
|
gptkbp:structureType
|
14-amino acid peptide
|
|
gptkbp:synonym
|
MD-1100
agonist of guanylate cyclase-C
|
|
gptkbp:UNII
|
3M0G870360
|
|
gptkbp:usedFor
|
chronic idiopathic constipation
irritable bowel syndrome with constipation
|
|
gptkbp:bfsParent
|
gptkb:Ironwood_Pharmaceuticals
|
|
gptkbp:bfsLayer
|
5
|